Circulating Tumor Cells in Esophageal Squamous Cell Carcinoma – Mini Review

References

• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424. doi:10.3322/caac.2149230207593
   PubMed Web of Science ®Google Scholar
• Sclafani F, Smyth E, Cunningham D, et al. Assessing the incidence and clinical significance of circulating tumor cells in esophagogastric cancers. Clin Colorectal Cancer. 2014;13(2):94–99. doi:10.1016/j.clcc.2013.11.00324332356
   PubMed Web of Science ®Google Scholar
• Li H, Song P, Zou B, et al. Circulating tumor cell analyses in patients with esophageal squamous cell carcinoma using epithelial marker-dependent and -independent approaches. Medicine (Baltimore). 2015;94(38):e1565. doi:10.1097/MD.000000000000156526402816
   PubMed Web of Science ®Google Scholar
• Kato H, Kuwano H, Nakajima M, et al. Usefulness of positron emission tomography for assessing the response of neoadjuvant chemoradiotherapy in patients with esophageal cancer. Am J Surg. 2002;184(3):279–283. doi:10.1016/S0002-9610(02)00932-712354600
   PubMed Web of Science ®Google Scholar
• Ikoma D, Ichikawa D, Ueda Y, et al. Circulating tumor cells and aberrant methylation as tumor markers in patients with esophageal cancer. Anticancer Res. 2007;27(1B):535–539.17348438
   PubMed Web of Science ®Google Scholar
• Takeuchi H, Miyata H, Gotoh M, et al. A risk model for esophagectomy using data of 5354 patients included in a Japanese nationwide web-based database. Ann Surg. 2014;260(2):259–266. doi:10.1097/SLA.000000000000064424743609
   PubMed Web of Science ®Google Scholar
• Elliott JA, Docherty NG, Eckhardt H-G, et al. Weight loss, satiety, and the postprandial gut hormone response after esophagectomy: a prospective study. Ann Surg. 2017;266(1):82–90. doi:10.1097/SLA.000000000000191827455150
   PubMed Web of Science ®Google Scholar
• Cooper JS, Guo MD, Herskovic A, et al. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. JAMA. 1999;281(17):1623–1627. doi:10.1001/jama.281.17.162310235156
   PubMed Web of Science ®Google Scholar
• Pennathur A, Gibson MK, Jobe BA, et al. Oesophageal carcinoma. Lancet. 2013;381(9864):400–412. doi:10.1016/S0140-6736(12)60643-623374478
   PubMed Web of Science ®Google Scholar
• Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2009. CA Cancer J Clin. 2009;59:225–249. doi:10.3322/caac.2000619474385
   PubMed Web of Science ®Google Scholar
• Howlader N, Noone AM, Krapcho M, et al. SEER Cancer Statistics Review, 1975–2013. Bethesda, MD, USA: National Cancer Institute; 2016.
   Google Scholar
• Lightdale CJ. Esophageal cancer. Am J Gastroenterol. 1999;94:20–29. doi:10.1111/j.1572-0241.1999.00767.x9934727
   PubMed Web of Science ®Google Scholar
• Faivre J, Forman D, Esteve J, Gatta G. Survival of patients with oesophageal and gastric cancers in Europe. EUROCARE Working Group. Eur J Cancer. 1998;34:2167–2175. doi:10.1016/S0959-8049(98)00329-310070283
   PubMed Web of Science ®Google Scholar
• Kosugi S, Nishimaki T, Kanda T, Nakagawa S, Ohashi M, Hatakeyama K. Clinical significance of serum carcinoembryonic antigen, carbohydrate antigen 19-9, and squamous cell carcinoma antigen levels in esophageal cancer patients. World J Surg. 2004;28(7):680–685. doi:10.1007/s00268-004-6865-y15383868
   PubMed Web of Science ®Google Scholar
• Paterlini-Brechot P, Benali NL. Circulating tumor cells (CTC) detection: clinical impact and future directions. Cancer Lett. 2007;253(2):180–204. doi:10.1016/j.canlet.2006.12.01417314005
   PubMed Web of Science ®Google Scholar
• Allard WJ, Matera J, Miller MC, et al. Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res. 2004;10:6897–6904. doi:10.1158/1078-0432.CCR-04-037815501967
   PubMed Web of Science ®Google Scholar
• Maheswaran S, Haber DA. Circulating tumor cells: a window into cancer biology and metastasis. Curr Opin Genet Dev. 2010;20:96–99. doi:10.1016/j.gde.2009.12.00220071161
   PubMed Web of Science ®Google Scholar
• Van Hagen P, Hulshof MC, van Lanschot JJ, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 2012;366:2074–2084. doi:10.1056/NEJMoa111208822646630
   PubMed Web of Science ®Google Scholar
• Matsushita D, Arigami T, Okubo K, et al. The diagnostic and prognostic value of a liquid biopsy for esophageal cancer: a systematic review and meta-analysis. Cancers (Basel). 2020;12(10):3070. doi:10.3390/cancers12103070
   PubMed Web of Science ®Google Scholar
• Galvis MM, Romero CS, Bueno TO, Teng Y. Toward a new era for the management of circulating tumor cells. Adv Exp Med Biol. 2021;1286:125–134.33725350
   PubMed Web of Science ®Google Scholar
• Pierga JY, Bidard FC, Mathiot C, et al. Circulating tumor cell detection predicts early metastatic relapse after neoadjuvant chemotherapy in large operable and locally advanced breast cancer in a Phase II randomized trial. Clin Cancer Res. 2008;14:7004–7010. doi:10.1158/1078-0432.CCR-08-003018980996
   PubMed Web of Science ®Google Scholar
• Camara O, Rengsberger M, Egbe A, et al. The relevance of circulating epithelial tumor cells (CETC) for therapy monitoring during neoadjuvant (primary systemic) chemotherapy in breast cancer. Ann Oncol. 2007;18:1484–1492. doi:10.1093/annonc/mdm20617761704
   PubMed Web of Science ®Google Scholar
• de Bono JS, Scher HI, Montgomery RB, et al. Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer. Clin Cancer Res. 2008;14(19):6302–6309. doi:10.1158/1078-0432.CCR-08-087218829513
   PubMed Web of Science ®Google Scholar
• Yousefi M, Ghaffari P, Nosrati R, et al. Prognostic and therapeutic significance of circulating tumor cells in patients with lung cancer. Cell Oncol (Dordr). 2020;43(1):31–49. doi:10.1007/s13402-019-00470-y31828552
   PubMed Web of Science ®Google Scholar
• Cohen SJ, Punt CJ, Iannotti N, et al. Meropol NJ: prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer. Ann Oncol. 2009;20(7):1223–1229. doi:10.1093/annonc/mdn78619282466
   PubMed Web of Science ®Google Scholar
• Yin XD, Yuan X, Xue JJ, Wang R, Zhang ZR, Tong JD. Clinical significance of carcinoembryonic antigen-, cytokeratin 19-, or survivin-positive circulating tumor cells in the peripheral blood of esophageal squamous cell carcinoma patients treated with radiotherapy. Dis Esophagus. 2012;25(8):750–756. doi:10.1111/j.1442-2050.2012.01326.x22394149
   PubMed Web of Science ®Google Scholar
• Cristofanilli M, Budd GT, Ellis MJ, et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med. 2004;351:781–791. doi:10.1056/NEJMoa04076615317891
   PubMed Web of Science ®Google Scholar
• Lucci A, Hall CS, Lodhi AK, et al. Circulating tumour cells in non-metastatic breast cancer: a prospective study. Lancet Oncol. 2012;13(7):688–695. doi:10.1016/S1470-2045(12)70209-722677156
   PubMed Web of Science ®Google Scholar
• Krebs MG, Sloane R, Priest L, et al. Evaluation and prognostic significance of circulating tumor cells in patients with non-small-cell lung cancer. J Clin Oncol. 2011;29:1556–1563. doi:10.1200/JCO.2010.28.704521422424
   PubMed Web of Science ®Google Scholar
• Iinuma H, Watanabe T, Mimori K, et al. Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes’ stage B and C colorectal cancer. J Clin Oncol. 2011;29:1547–1555. doi:10.1200/JCO.2010.30.515121422427
   PubMed Web of Science ®Google Scholar
• Scher HI, Jia X, de Bono JS, et al. Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data. Lancet Oncol. 2009;10:233–239. doi:10.1016/S1470-2045(08)70340-119213602
   PubMed Web of Science ®Google Scholar
• Reeh M, Effenberger KE, Koenig AM, et al. Circulating tumor cells as a biomarker for preoperative prognostic staging in patients with esophageal cancer. Ann Surg. 2015;261(6):1124–1130.25607767
   PubMed Web of Science ®Google Scholar
• Joosse SA, Gorges TM, Pantel K. Biology, detection, and clinical implications of circulating tumor cells. EMBO Mol Med. 2015;7(1):1–11. doi:10.15252/emmm.20130369825398926
   PubMed Web of Science ®Google Scholar
• Liberko M, Kolostova K, Bobek V. Essentials of circulating tumor cells for clinical research and practice. Crit Rev Oncol Hematol. 2013;88(2):338–356. doi:10.1016/j.critrevonc.2013.05.00223830807
   PubMed Web of Science ®Google Scholar
• Han L, Li YJ, Zhang WD, Song PP, Li H, Li S. Clinical significance of tumor cells in the peripheral blood of patients with esophageal squamous cell carcinoma. Medicine (Baltimore). 2019;98(6):e13921. doi:10.1097/MD.000000000001392130732126
   PubMed Web of Science ®Google Scholar
• Choi MK, Kim GH, H I, et al. Circulating tumor cells detected using fluid-assisted separation technique in esophageal squamous cell carcinoma. J Gastroenterol Hepatol. 2019;34(3):552–560.30426559
   PubMed Web of Science ®Google Scholar
• Sleijfer S, Gratama JW, Sieuwerts AM, Kraan J, Martens JW, Foekens JA. Circulating tumour cell detection on its way to routine diagnostic implementation? Eur J Cancer. 2007;43:2645–2650. doi:10.1016/j.ejca.2007.09.01617977713
   PubMed Web of Science ®Google Scholar
• Reeh M, Effenberger KE, Koenig AM, et al. Circulating tumor cells as a biomarker for preoperative prognostic staging in patients with esophageal cancer. Ann Surg. 2015;261(6):1124–1130.25607767
   PubMed Web of Science ®Google Scholar
• Khoja L, Backen A, Sloane R, et al. A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker. Br J Cancer. 2012;106:508–516. doi:10.1038/bjc.2011.54522187035
   PubMed Web of Science ®Google Scholar
• Farace F, Massard C, Vimond N, et al. A direct comparison of CellSearch and ISET for circulating tumour-cell detection in patients with metastatic carcinomas. Br J Cancer. 2011;105:847–853. doi:10.1038/bjc.2011.29421829190
   PubMed Web of Science ®Google Scholar
• Krebs MG, Hou JM, Sloane R, et al. Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and -independent approaches. J Thorac Oncol. 2012;7:306–315. doi:10.1097/JTO.0b013e31823c5c1622173704
   PubMed Web of Science ®Google Scholar
• Kuvendjiska J, Bronsert P, Martini V, et al. Non-metastatic esophageal adenocarcinoma: circulating tumor cells in the course of multimodal tumor treatment. Cancers (Basel). 2019;11(3):397. doi:10.3390/cancers11030397
   PubMed Web of Science ®Google Scholar
• Kim TH, Lim M, Park J, et al. FAST: size-selective, clog-free isolation of rare cancer cells from whole blood at a liquid-liquid interface. Anal Chem. 2017;89(2):1155–1162. doi:10.1021/acs.analchem.6b0353427958721
   PubMed Web of Science ®Google Scholar
• Qiao GL, Qi WX, Jiang WH, Chen Y, Ma LJ. Prognostic significance of circulating tumor cells in esophageal carcinoma: a meta-analysis. Onco Targets Ther. 2016;31(9):1889–1897. doi:10.2147/OTT.S100005
   Web of Science ®Google Scholar
• Eisenberger CF, Knoefel WT, Peiper M, et al. Squamous cell carcinoma of the esophagus can be detected by microsatellite analysis in tumor and serum. Clin Cancer Res. 2003;9(11):4178–4183.14519643
   PubMed Web of Science ®Google Scholar
• Fidler IJ. The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited. Nat Rev Cancer. 2003;3(6):453–458. doi:10.1038/nrc109812778135
   PubMed Web of Science ®Google Scholar
• Chaffer CL, Weinberg RA. A perspective on cancer cell metastasis. Science. 2011;331(6024):1559–1564. doi:10.1126/science.120354321436443
   PubMed Web of Science ®Google Scholar
• Liu Z, Jiang M, Zhao J, Ju H. Circulating tumor cells in perioperative EC patients: quantitative assay system and potential clinical utility. Clin Cancer Res. 2007;13(10):2992–2997. doi:10.1158/1078-0432.CCR-06-207217505001
   PubMed Web of Science ®Google Scholar
• Kaganoi J, Shimada Y, Kano M, Okumura T, Watanabe G, Imamura M. Detection of circulating oesophageal squamous cancer cells in peripheral blood and its impact on prognosis. Br J Surg. 2004;91(8):1055–1060. doi:10.1002/bjs.459315286970
   PubMed Web of Science ®Google Scholar
• Su PJ, Wu MH, Wang HM, et al. Circulating tumour cells as an independent prognostic factor in patients with advanced oesophageal squamous cell carcinoma undergoing chemoradiotherapy. Sci Rep. 2016;6:31423. doi:10.1038/srep3142327530152
   PubMed Web of Science ®Google Scholar
• Andolfo I, Petrosino G, Vecchione L, et al. Detection of erbB2 copy number variations in plasma of patients with esophageal carcinoma. BMC Cancer. 2011;11:126. doi:10.1186/1471-2407-11-12621481261
   PubMed Web of Science ®Google Scholar
• Qiao Y, Li J, Shi C, et al. Prognostic value of circulating tumor cells in the peripheral blood of patients with esophageal squamous cell carcinoma. Onco Targets Ther. 2017;3(10):1363–1373. doi:10.2147/OTT.S129004
   Web of Science ®Google Scholar
• Tanaka K, Yano M, Motoori M, et al. CEA-antigen and SCC-antigen mRNA expression in peripheral blood predict hematogenous recurrence after resection in patients with esophageal cancer. Ann Surg Oncol. 2010;17(10):2779–2786. doi:10.1245/s10434-010-1075-320411433
   PubMed Web of Science ®Google Scholar
• Schneider PM, Metzger R, Schaefer H, et al. Response evaluation by endoscopy, rebiopsy, and endoscopic ultrasound does not accurately predict histopathologic regression after neoadjuvant chemoradiation for esophageal cancer. Ann Surg. 2008;248:902–908. doi:10.1097/SLA.0b013e31818f3afb19092334
   PubMed Web of Science ®Google Scholar
• Westerterp M, van Westreenen HL, Reitsma JB, et al. Esophageal cancer: CT, endoscopic US, and FDG PET for assessment of response to neoadjuvant therapy–systematic review. Radiology. 2005;236:841–851. doi:10.1148/radiol.236304104216118165
   PubMed Web of Science ®Google Scholar
• Qiao YY, Lin KX, Zhang Z, et al. Monitoring disease progression and treatment efficacy with circulating tumor cells in esophageal squamous cell carcinoma: a case report. World J Gastroenterol. 2015;21(25):7921–7928. doi:10.3748/wjg.v21.i25.792126167094
   PubMed Web of Science ®Google Scholar
• Nakashima S, Natsugoe S, Matsumoto M, et al. Clinical significance of circulating tumor cells in blood by molecular detection and tumor markers in esophageal cancer. Surgery. 2003;133(2):162–169. doi:10.1067/msy.2003.912605177
   PubMed Web of Science ®Google Scholar
• Cao M, Yie SM, Wu SM, et al. Detection of survivin-expressing circulating cancer cells in the peripheral blood of patients with esophageal squamous cell carcinoma and its clinical significance. Clin Exp Metastasis. 2009;26(7):751–758. doi:10.1007/s10585-009-9274-719521785
   PubMed Web of Science ®Google Scholar
• Matsushita D, Uenosono Y, Arigami T, et al. Clinical significance of circulating tumor cells in peripheral blood of patients with esophageal squamous cell carcinoma. Ann Surg Oncol. 2015;22:3674–3680. doi:10.1245/s10434-015-4392-825652049
   PubMed Web of Science ®Google Scholar
• Zhao Y, Han L, Zhang W, et al. Preoperative chemotherapy compared with postoperative adjuvant chemotherapy for squamous cell carcinoma of the thoracic oesophagus with the detection of circulating tumour cells randomized controlled trial. Int J Surg. 2020;73:1–8. doi:10.1016/j.ijsu.2019.11.00531756547
   PubMed Web of Science ®Google Scholar
• Klein CA. Parallel progression of primary tumours and metastases. Nat Rev Cancer. 2009;9:302–312. doi:10.1038/nrc262719308069
   PubMed Web of Science ®Google Scholar
• Sclafani F, Smyth E, Cunningham D, Chau I, Turner A, Watkins D. A pilot study assessing the incidence and clinical significance of circulating tumor cells in esophagogastric cancers. Clin Colorectal Cancer. 2014;13(2):94–99.24332356
   PubMed Web of Science ®Google Scholar
• Tsai WS, Hung TF, Chen JY, Huang SH, Chang YC. Early detection and dynamic changes of circulating tumor cells in transgenic NeuN Transgenic (NTTg) mice with spontaneous breast tumor development. Cancers (Basel). 2021;13(13):3294. doi:10.3390/cancers1313329434209279
   PubMed Web of Science ®Google Scholar
• Lee HJ, Kim GH, Park SJ, et al. Clinical significance of TWIST-positive circulating tumor cells in patients with esophageal squamous cell carcinoma. Gut Liver. 2021;15(4):553–561. doi:10.5009/gnl2019433293482
   PubMed Web of Science ®Google Scholar
• Schwarzenbach H, Hoon DSB, Pantel K. Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev Cancer. 2011;11:426–437. doi:10.1038/nrc306621562580
   PubMed Web of Science ®Google Scholar
• Leng S, Zheng J, Jin Y, et al. Plasma cell-free DNA level and its integrity as biomarkers to distinguish non-small cell lung cancer from tuberculosis. Clin Chim Acta. 2018;477:160–165. doi:10.1016/j.cca.2017.11.00329113814
   PubMed Web of Science ®Google Scholar
• Pinsky PF, Prorok PC, Kramer BS. Prostate cancer screening - a perspective on the current state of the evidence. N Engl J Med. 2017;376(13):1285–1289. doi:10.1056/NEJMsb161628128355509
   PubMed Web of Science ®Google Scholar